Autoimmune Diseases  >>  GSK315234  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GSK315234 / GSK
NCT00674635: Phase II Study Evaluating the Safety and Efficacy of GSK315234A in Patients With Rheumatoid Arthritis

Checkmark Rheumatoid arthritis
Nov 2013 - Nov 2013: Rheumatoid arthritis
Completed
2
135
RoW
GSK3152314A, Placebo
GlaxoSmithKline
Arthritis, Rheumatoid
12/10
12/10

Download Options